Inlexzo is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Inlexzo is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameInlexzo
Authorized genericgemcitabine intravesical
Regular genericgemcitabine intravesical
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Inlexzo?
The original
–
–

Brand nameThe maker’s card

J&J withMe Savings Program

Savings card from Johnson & Johnson

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $5 a treatment

Sign up on jnjwithme.com 

Or call 1-833-565-9631.

In the maker’s words

“Eligible patients pay $5 per treatment for INLEXZO™ out-of-pocket treatment costs and $0 per treatment for certain treatment administration costs.”

From the maker’s offer on jnjwithme.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Inlexzo itself, from the same company, sold without the brand name, and usually for less. For now Inlexzo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

INLEXZO is a nucleoside metabolic inhibitor-containing intravesical system, indicated for the treatment of adult patients with Bacillus Calmette-Guérin (BCG)-unresponsive, non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ(CIS) with or without papillary tumors.

Source: the FDA label for Inlexzo (Janssen Biotech, Inc), September 11, 2025. Full label on DailyMed 

Good to know